Understanding human body composition in the first two years of life

Historical challenges associated with the assessment of body composition in the first two years of life.

AEON fails another migraine trial, shares halve as company reviews options

AEON Biopharma said its botulinum toxin treatment candidate failed a Phase 2 migraine study at the planned interim analysis. The company’s share price $AEON was

May 4, 2024

King Charles’ Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?

Note that some links may require registration or subscription. People close to King Charles III are concerned his packed schedule could affect his cancer recovery.

August 27, 2024

Optibrium launches a metabolism prediction software platform tailored to DMPK scientists

Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discove.ry

February 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.